1.Peters, J, Schlaghecke, R, Thouet, H, Arndt, JO. Endogenous vasopressin supports blood pressure and prevents severe hypotension during epidural anesthesia in conscious dogs. Anesthesiology 1990; 73: 694–702.
2.Hopf, H-B, Schlaghecke, R, Peters, J. Sympathetic neural blockade by thoracic epidural anesthesia suppresses renin release in response to arterial hypotension. Anesthesiology 1994; 80: 992–999.
3.Weber, C, Schmitt, R, Birnboeck, H et al. . Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects. Clin Pharmacol Therapeut 1996; 60: 124–137.
4.Munter, K, Ehmke, H, Kirchengast, H. Maintenance of blood pressure in normotensive dogs by endothelin. Am J Physiol 1999; 45: H1022–H1027.
5.Notarius, CF, Erice, F, Stewart, D, Magder, S. Effect of baroreceptor activation and systemic hypotension on plasma endothelin 1 and neuropeptide Y. Can J Physiol Pharmacol 1995; 73: 1136–1143.
6.Cernacek, P, Stewart, DJ, Levy, M. Plasma endothelin-1 response to acute hypotension induced by vasodilating agents. Can J Physiol Pharmacol 1994; 72: 985–991.
7.Picker, O, Schindler, AW, Scheeren, TWL. Endogenous endothelin and vasopressin support blood pressure during epidural anesthesia in conscious dogs. Anesth Analg 2001; 93: 1580–1586.
8.Banting, JD, Friberg, P, Adams, MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertension 1996; 14: 975–981.
9.Qiu, C, Engels, K, Baylis, C. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade. J Am Soc Nephrol 1995; 6: 1476–1481.
10.Tagawa, T, Imaizumi, T, Endo, T et al. . Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest 1993; 92: 1483–1490.
11.Yamada, K, Nakayama, M, Nakano, H, Mimura, N, Yoshida, S. Endothelium-dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta. J Physiol 1993; 264: E203–E207.
12.Liard, JF. l-NAME antagonizes vasopressin V2-induced vasodilation in dogs. Am J Physiol 1994; 266: H99–H106.
13.Pucci, ML, Lin, L, Nasjletti, A. Pressor and renal vasoconstrictor effects of NG-nitro-l-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin. J Pharmacol Exp Ther 1992; 261 (1): 240–245.
14.Picker, O, Wietasch, G, Scheeren, TW, Arndt, JO. Determination of total blood volume by indicator dilution: a comparison of mean transit time and mass conservation principle. Intens Care Med 2001; 27: 767–774.
15.Evans, HE, Christensen, GC. Millar's Anatomy of the Dog. W.B. Saunders: Philadelphia, 1979.
16.Takamura, M, Parent, R, Cernacek, P, Lavallee, M. Influence of dual ET(A)/ET(B)-receptor blockade on coronary responses to treadmill exercise in dogs. J Appl Physiol 2000; 89: 2041–2048.
17.Kruszynski, M, Lammek, B, Manning, M et al. . [1-Beta-mercapto-beta, beta-cyclopentamethylenepropionic acid), 2-(O- methyl)tyrosine] argine–vasopressin and [1-beta-mercapto-beta, beta-cyclopentamethylenepropionic acid)] argine–vasopressine, two highly potent antagonists of the vasopressor response to arginine–vasopressin. J Med Chem 1980; 23: 364–368.
18.Tabrizi-Fard, M, Fung, H. Pharmacocinetics, plasma protein binding and urinary excretion of N-omega-nitro-l-arginine in rats. Br J Pharmacol 1994; 111: 394–396.
19.Sandgaard, NC, Bie, P. Natriuretic effect of non-pressor doses of endothelin-1 in conscious dogs. J Physiol (London) 1996; 494: 809–818.
20.Howl, J, Wheatley, M. Molecular pharmacology of V1a vasopressin receptors. Gen Pharmacol 1995; 26: 1143–1152.
21.Peters, J, Kousoulis, L, Arndt, JO. Effects of segmental thoracic extradural analgesia on sympathetic block in conscious dogs. Br J Anaesth 1989; 63: 470–476.
22.Hogan, QH, Stadnicka, A, Stekiel, TA, Bosnjak, ZJ, Kampine, JP. Effects of epidural and systemic lidocaine on sympathetic activity and mesenteric circulation in rabbits. Anaesthesiology 1993; 79: 1250–1260.
23.Pollard, BJ. Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention. Anesth Analg 2002; 92: 252–256.
24.Hasser, EM, Bishop, VS. Neurogenic and humoral factors maintaining arterial pressure in conscious dogs. Am J Physiol 1988; 255: R693–R698.
25.Thrasher, TN, Chen, HG, Keil, LC. Arterial baroreceptors control plasma vasopressin responses to graded hypotension in conscious dogs. Am J Physiol Regul Integr Comp Physiol 2000; 278: R469–R475.
26.Moncada, S, Palmer, RM, Higgs, EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–142.
27.Hirata, Y, Hayakawa, H, Kakoki, M et al. . Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney. Hypertension 1997; 29: 58–64.
28.Hasser, EM, Cunningham, JT, Sullivan, MJ, Curtis, KS, Blaine, EH, Hay, M. Area postrema and sympathetic nervous system effects of vasopressin and angiotensin II. Clin Exp Pharmacol Physiol 2000; 27: 432–436.
29.Boulanger, C, Luscher, TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85: 587–590.
30.Kleinbongard, P, Dejam, A, Lauer, T et al. . Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Rad Biol Med 2003; 35: 790–796.
31.Goertz, A, Heinrich, H, Seeling, W. Baroreflex control of heart rate during high thoracic epidural anaesthesia. A randomised clinical trial on anaesthetised humans. Anaesthesia 1992; 47: 984–987.
32.Picker, O, Scheeren, TW, Arndt, JO. Nitric oxide synthases in vagal neurons are crucial for the regulation of heart rate in awake dogs. Basic Res Cardiol 2001; 96: 395–404.